FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Silke Gillessen

Research Profile

Anatomy

Dendritic Cells

Chemicals & Drugs

Disorders

Living Beings

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Christian Rothermundt; Silke Gillessen
Angioedema in a patient with renal cell cancer treated with everolimus in combination with an angiotensin-converting enzyme inhibitor.
Richard Cathomas; Denise Cotting; Cornelia Droege; Silke Gillessen; Rolf Jaggi; Dirk Klingbiel; Miklos Pless; Christian Rothermundt; Ralph Schiess; Daniele Siciliano; Roger von Moos; Ralph Winterhalder; Dominik R Berthold; Daniel C Betticher; Peter Brauchli; Lukas Bubendorf
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07).
Nicola L Schoenewolf; Peter Schraml; Mathew Simcock; Roger von Moos; Reinhard Dummer; Silke Gillessen; Daniela Mihic-Probst; Holger Moch; Adrian Ochsenbein
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Silke Gillessen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christian Rothermundt; Silke Gillessen
Angioedema in a patient with renal cell cancer treated with everolimus in combination with an angiotensin-converting enzyme inhibitor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(5):e57-8.
2012: Richard Cathomas; Denise Cotting; Cornelia Droege; Silke Gillessen; Rolf Jaggi; Dirk Klingbiel; Miklos Pless; Christian Rothermundt; Ralph Schiess; Daniele Siciliano; Roger von Moos; Ralph Winterhalder; Dominik R Berthold; Daniel C Betticher; Peter Brauchli; Lukas Bubendorf
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07).
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(21):6049-57.
2012: Nicola L Schoenewolf; Peter Schraml; Mathew Simcock; Roger von Moos; Reinhard Dummer; Silke Gillessen; Daniela Mihic-Probst; Holger Moch; Adrian Ochsenbein
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques.
Case reports in oncology 2012;5(2):280-9.
2011: Martin Kälin; Wilhelm Krek; Tom Powles; Ralph Schiess; Arnoud Templeton; Peter Wild; Ruedi Aebersold; Thomas Cerny; Igor Cima; Niklaus Fankhauser; Silke Gillessen
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome.
European urology 2011;60(6):1235-43.
2010: Silke Gillessen; Arnoud Templeton; Giancarlo Marra; Yong-Fang Kuo; Emanuele Valtorta; Vahakn B Shahinian
Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.
Journal of the National Cancer Institute 2010;102(23):1760-70.
2009: Arnoud Templeton; Giancarlo Marra; Emanuele Valtorta; Karl Heinimann; Hansjakob Müller; Dieter Köberle; Silke Gillessen
Concordant colon tumors in monozygotic twins previously treated for prostate cancer.
Familial cancer 2009;8(2):167-71.
2008: M Früh; Silke Gillessen; T Cerny; R Demmer; G D'Addario
Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;62(3):344-50.
2008: Markus Joerger; Dominique F Nuessli; Samuel Henz; Wolfgang Zaunbauer; Thomas Cerny; Sergio B Cogliatti; Silke Gillessen
CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study.
Onkologie 2008;31(10):514-9.
2008: Arnoud Templeton; Silvia Hofer; Michael Töpfer; Andreas Sommacal; Christian Fretz; Thomas Cerny; Silke Gillessen
Extraneural spread of glioblastoma--report of two cases.
Onkologie 2008;31(4):192-4.
2008: Florian Strasser; Ruth Demmer; Christel Böhme; Shu-Fang Hsu Schmitz; Beat Thuerlimann; Thomas Cerny; Silke Gillessen
Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study.
The oncologist 2008;13(3):337-46.
2007: Simone Steinbild; Klaus Mross; Annette Frost; Rudolf Morant; Silke Gillessen; Christian Dittrich; Dirk Strumberg; A Hochhaus; Axel R Hanauske; L Edler; Iris Burkholder; Max E Scheulen
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
British journal of cancer 2007;97(11):1480-5.
2007: Thomas Enzler; Silke Gillessen; Michael Dougan; James P Allison; Donna Neuberg; Darryl A Oble; Martin Mihm; Glenn Dranoff
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.
Blood 2007;110(3):954-61.
2007: Lukas von Rohr; Bernd Klaeser; Markus Joerger; Thomas Kluckert; Thomas Cerny; Silke Gillessen
Increased pulmonary FDG uptake in bleomycin-associated pneumonitis.
Onkologie 2007;30(6):320-3.
2007: Silke Gillessen; Lukas Graf; Wolfgang C. Korte; Thomas Cerny
Macrocytosis and cobalamin deficiency in patients treated with sunitinib.
The New England journal of medicine 2007;356(22):2330-1.
2007: R Inauen; Richard Cathomas; T Boehm; Dieter Koeberle; Bernhard C Pestalozzi; Silke Gillessen; Roger von Moos
Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure.
Oncology 2007;72(3-4):209-10.
2006: Ying Waeckerle-Men; Edith Uetz-Von Allmen; Markus Fopp; Roger von Moos; Christel Böhme; Hans-Peter Schmid; Daniel Ackermann; Thomas Cerny; Burkhard Ludewig; Marcus Groettrup; Silke Gillessen
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.
Cancer immunology, immunotherapy : CII 2006;55(12):1524-33.
2006: Marc Roger Schlaeppi; Wolfgang C. Korte; Roger von Moos; Thomas Cerny; Silke Gillessen
Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma.
Onkologie 2006;29(11):531-3.
2006: Monika Jermann; Rolf A Stahel; Marc Salzberg; Thomas Cerny; Markus Joerger; Silke Gillessen; Rudolf Morant; Fritz Egli; Kaspar Rhyner; Jean A Bauer; Miklos Pless
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma.
Cancer chemotherapy and pharmacology 2006;57(4):533-9.
2005: Ying Waeckerle-Men; Edith Uetz-von Allmen; Roger von Moos; Brendan J Classon; Elke Scandella; Hans-Peter Schmid; Burkhard Ludewig; Marcus Groettrup; Silke Gillessen
Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulation.
The Prostate 2005;64(4):323-31.
2005: Edward E S Nieuwenhuis; Silke Gillessen; Rik J Scheper; Mark A Exley; Masaru Taniguchi; Steven P Balk; Jack L Strominger; Glenn Dranoff; Richard S Blumberg; S Brian Wilson
CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity.
Experimental dermatology 2005;14(4):250-8.
2005: Markus Joerger; Dieter Koeberle; Hartmut P H Neumann; Silke Gillessen
Von Hippel-Lindau disease--a rare disease important to recognize.
Onkologie 2005;28(3):159-63.
2005: L Wuermli; Markus Joerger; S Henz; H-P Schmid; W F Riesen; G Thomas; W Krek; T Cerny; Silke Gillessen
Hypertriglyceridemia as a possible risk factor for prostate cancer.
Prostate cancer and prostatic diseases 2005;8(4):316-20.
2004: Ladislav Prikler; Elke Scandella; Ying Men; Daniel S Engeler; Pierre-Andre Diener; Silke Gillessen; B Ludewig; Hans-Peter Schmid
[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens].
Aktuelle Urologie 2004;35(4):326-30.
2004: Thomas Cerny; Felicitas Hitz; Silke Gillessen
[Mabthera for treatment of malignant lymphoma].
Therapeutische Umschau. Revue thérapeutique 2004;61(6):379-83.
2004: Rudolf Morant; Jürg Bernhard; Daniel Dietrich; Silke Gillessen; M Bonomo; Markus M Borner; J Bauer; Thomas Cerny; Christoph Rochlitz; Marion Wernli; A Gschwend; Silvia Hanselmann; Franz Hering; H-P Schmid
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial.
British journal of cancer 2004;90(7):1312-7.
2004: Ying Waeckerle-Men; Elke Scandella; Edith Uetz-Von Allmen; Burkhard Ludewig; Silke Gillessen; Hans P Merkle; Bruno Gander; Marcus Groettrup
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
Journal of immunological methods 2004;287(1-2):109-24.
2004: Markus Joerger; T Warzinek; Bernd Klaeser; J T Kluckert; Hans-Peter Schmid; Silke Gillessen
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer.
Urology 2004;63(4):778-80.
2004: Elke Scandella; Ying Men; Daniel F Legler; Silke Gillessen; Ladislav Prikler; Burkhard Ludewig; Marcus Groettrup
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2.
Blood 2004;103(5):1595-601.
2003: Robert J Soiffer; F Stephen Hodi; Frank G Haluska; Ken Jung; Silke Gillessen; Samuel Singer; Kenneth Tanabe; Rosemary B Duda; Steven J Mentzer; Michael T Jaklitsch; Raphael Bueno; Shirley Clift; Steve Hardy; Donna Neuberg; Richard Mulligan; Iain Webb; Martin Mihm; Glenn Dranoff
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3343-50.
2003: Silke Gillessen; Yuri N Naumov; Edward E S Nieuwenhuis; Mark A Exley; Frederick S Lee; Nicolas Mach; Andrew D Luster; Richard S Blumberg; Masaru Taniguchi; Steven P Balk; Jack L Strominger; Glenn Dranoff; S Brian Wilson
CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(15):8874-9.
2003: Thomas Enzler; Silke Gillessen; John P Manis; David O Ferguson; James Fleming; Frederick W Alt; Martin Mihm; Glenn Dranoff
Deficiencies of GM-CSF and interferon gamma link inflammation and cancer.
The Journal of experimental medicine 2003;197(9):1213-9.
2003: Roger von Moos; Rahel Stolz; Thomas Cerny; Silke Gillessen
Thalidomide: from tragedy to promise.
Swiss medical weekly 2003;133(5-6):77-87.
2002: Markus Joerger; C Oehlschlegel; Thomas Cerny; Silke Gillessen
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin.
Onkologie 2002;25(6):558-61.
2002: Silke Gillessen; M Groettup; Thomas Cerny
The proteasome, a new target for cancer therapy.
Onkologie 2002;25(6):534-9.
2002: Elke Scandella; Ying Men; Silke Gillessen; Reinhold Förster; Marcus Groettrup
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.
Blood 2002;100(4):1354-61.
2002: Thomas Cerny; Silke Gillessen
Advances in the treatment of non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():211-6.
2001: S Li; Silke Gillessen; Michael H Tomasson; Glenn Dranoff; D Gary Gilliland; Richard A Van Etten
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.
Blood 2001;97(5):1442-50.
2001: Michael H Tomasson; Ifor Williams; S Li; Jeffery L Kutok; D Cain; Silke Gillessen; Glenn Dranoff; Richard A Van Etten; D Gary Gilliland
Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3.
Blood 2001;97(5):1435-41.
2001: Silke Gillessen; Nicolas Mach; C Small; Martin Mihm; Glenn Dranoff
Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity.
Blood 2001;97(4):922-8.
2001: Takanori Teshima; Nicolas Mach; GR Hill; L Pan; Silke Gillessen; Glenn Dranoff; James L M Ferrara
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.
Cancer research 2001;61(1):162-71.
2000: Nicolas Mach; Silke Gillessen; S Brian Wilson; C Sheehan; Martin Mihm; Glenn Dranoff
Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
Cancer research 2000;60(12):3239-46.